Safety and efficacy of first-line bevacizumab with FOLFOX, XELOX, FOLFIRI and fluoropyrimidines in metastatic colorectal cancer: the BEAT study
Van Cutsem, E., Rivera, F., Berry, S., Kretzschmar, A., Michael, M., DiBartolomeo, M., Mazier, M.-A., Canon, J.-L., Georgoulias, V., Peeters, M., Bridgewater, J., Cunningham, D.
Published in Annals of oncology (01.11.2009)
Published in Annals of oncology (01.11.2009)
Get full text
Journal Article
Letrozole and palbociclib versus chemotherapy as neoadjuvant therapy of high-risk luminal breast cancer
Cottu, P., D'Hondt, V., Dureau, S., Lerebours, F., Desmoulins, I., Heudel, P.-E., Duhoux, F.P., Levy, C., Mouret-Reynier, M.-A., Dalenc, F., Frenel, J.-S., Jouannaud, C., Venat-Bouvet, L., Nguyen, S., Ferrero, J.-M., Canon, J.-L., Grenier, J., Callens, C., Gentien, D., Lemonnier, J., Vincent-Salomon, A., Delaloge, S.
Published in Annals of oncology (01.12.2018)
Published in Annals of oncology (01.12.2018)
Get full text
Journal Article
Final results from PRIME: randomized phase III study of panitumumab with FOLFOX4 for first-line treatment of metastatic colorectal cancer
Douillard, J.Y., Siena, S., Cassidy, J., Tabernero, J., Burkes, R., Barugel, M., Humblet, Y., Bodoky, G., Cunningham, D., Jassem, J., Rivera, F., Kocákova, I., Ruff, P., Błasińska-Morawiec, M., Šmakal, M., Canon, J.L., Rother, M., Oliner, K.S., Tian, Y., Xu, F., Sidhu, R.
Published in Annals of oncology (01.07.2014)
Published in Annals of oncology (01.07.2014)
Get full text
Journal Article
Phase II study of everolimus in patients with locally advanced or metastatic transitional cell carcinoma of the urothelial tract: clinical activity, molecular response, and biomarkers
Seront, E., Rottey, S., Sautois, B., Kerger, J., D'Hondt, L.A., Verschaeve, V., Canon, J.-L., Dopchie, C., Vandenbulcke, J.M., Whenham, N., Goeminne, J.C., Clausse, M., Verhoeven, D., Glorieux, P., Branders, S., Dupont, P., Schoonjans, J., Feron, O., Machiels, J.-P.
Published in Annals of oncology (01.10.2012)
Published in Annals of oncology (01.10.2012)
Get full text
Journal Article
Web Resource
Atezolizumab with or without cobimetinib versus regorafenib in previously treated metastatic colorectal cancer (IMblaze370): a multicentre, open-label, phase 3, randomised, controlled trial
Eng, Cathy, Kim, Tae Won, Bendell, Johanna, Argilés, Guillem, Tebbutt, Niall C, Di Bartolomeo, Maria, Falcone, Alfredo, Fakih, Marwan, Kozloff, Mark, Segal, Neil H, Sobrero, Alberto, Yan, Yibing, Chang, Ilsung, Uyei, Anne, Roberts, Louise, Ciardiello, Fortunato, Ahn, JB, Asselah, J, Badarinath, S, Baijal, S, Begbie, S, Berry, S, Canon, JL, Carbone, RG, Cervantes, A, Cha, YJ, Chang, K, Chaudhry, A, Chmielowska, E, Cho, SH, Chu, D, Couture, F, Cultrera, J, Cunningham, D, Van Cutsem, E, Cuyle, PJ, Davies, J, Dowden, S, Dvorkin, M, Ganju, V, Garcia, RV, Kerr, R, Kim, TY, King, K, Kortmansky, J, Kozloff, M, Lam, KO, Lee, J, Lee, AS, Lesperance, B, Luppi, G, Ma, B, Maiello, E, Mandanas, R, Marshall, J, Marx, G, Mullamitha, S, Nechaeva, M, Park, JO, Pavlakis, N, Ponce, CG, Potemski, P, Raouf, S, Reeves, J, Segal, N, Siena, S, Smolin, A, Streb, JO, Strickland, A, Szutowicz-Zielinska, E, Tabernero, JM, Tan, B, Valera, JS, Van den Eynde, M, Vergauwe, P, Vickers, M, Womack, M, Wroblewska, M, Young, R
Published in The lancet oncology (01.06.2019)
Published in The lancet oncology (01.06.2019)
Get full text
Journal Article
Impact of the line of treatment on progression-free survival in patients treated with T-DM1 for metastatic breast cancer
Migeotte, A, Dufour, V, van Maanen, A, Berliere, M, Canon, J L, Taylor, D, Duhoux, F P
Published in BMC cancer (11.11.2021)
Published in BMC cancer (11.11.2021)
Get full text
Journal Article
Phase I/II study of preoperative cetuximab, capecitabine, and external beam radiotherapy in patients with rectal cancer
Machiels, J-P, Sempoux, C, Scalliet, P, Coche, J-C, Humblet, Y, Van Cutsem, E, Kerger, J, Canon, J-L, Peeters, M, Aydin, S, Laurent, S, Kartheuser, A, Coster, B, Roels, S, Daisne, J-F, Honhon, B, Duck, L, Kirkove, C, Bonny, M-A, Haustermans, K
Published in Annals of oncology (01.04.2007)
Published in Annals of oncology (01.04.2007)
Get full text
Journal Article
An open-label, single-arm study assessing safety and efficacy of panitumumab in patients with metastatic colorectal cancer refractory to standard chemotherapy
Van Cutsem, E., Siena, S., Humblet, Y., Canon, J.-L., Maurel, J., Bajetta, E., Neyns, B., Kotasek, D., Santoro, A., Scheithauer, W., Spadafora, S., Amado, R. G., Hogan, N., Peeters, M.
Published in Annals of oncology (01.01.2008)
Published in Annals of oncology (01.01.2008)
Get full text
Journal Article
Efficacy of olaparib in advanced cancers with germline or somatic mutations in BRCA1, BRCA2, CHEK2 and ATM, a Belgian Precision tumor-agnostic phase II study
Joris, S., Denys, H., Collignon, J., Rasschaert, M., T’Kint de Roodenbeke, D., Duhoux, F.P., Canon, J.-L., Tejpar, S., Mebis, J., Decoster, L., Aftimos, P., De Grève, J.
Published in ESMO open (01.12.2023)
Published in ESMO open (01.12.2023)
Get full text
Journal Article
Web Resource
Phase II study of preoperative oxaliplatin, capecitabine and external beam radiotherapy in patients with rectal cancer: the RadiOxCape study
Machiels, J.-P., Duck, L., Honhon, B., Coster, B., Coche, J.-C., Scalliet, P., Humblet, Y., Aydin, S., Kerger, J., Remouchamps, V., Canon, J.-L., Van Maele, P., Gilbeau, L., Laurent, S., Kirkove, C., Octave-Prignot, M., Baurain, J.-F., Kartheuser, A., Sempoux, C.
Published in Annals of oncology (01.12.2005)
Published in Annals of oncology (01.12.2005)
Get full text
Journal Article
A phase Ib/II study of durvalumab combined with dose-dense EC in neoadjuvant setting for patients with locally advanced luminal B HER2(-) or triple negative breast cancers (B-IMMUNE)
Devaux, A., Canon, J.-L., Duhoux, F.P., Delrée, P., Galant, C., Coulie, P.G., Bar, I., Constant, M., Haussy, S., Bricard, O., Missault, K., Berlière, M., Willems, T., Carrasco, J.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Phase I studies assessing the safety and clinical activity of multiple doses of a NKG2D-based CAR-T therapy, CYAD-01, in metastatic colorectal cancer
Flament, A., Hendlisz, A., Shaza, L., Aspeslagh, S., Vouche, M., Donckier, V., Awada, A., Machiels, J.-P., van den Eynde, M., Canon, J.-L., Carrasco, J., Lonez, C., Lehmann, F.F.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Flexible care in breast cancer
Wardley, A., Canon, J.-L., Elsten, L., Peña Murillo, C., Badovinac Crnjevic, T., Fredriksson, J., Piccart, M.
Published in ESMO open (01.02.2021)
Published in ESMO open (01.02.2021)
Get full text
Journal Article
Multicenter phase II randomized trial evaluating antiangiogenic therapy with sunitinib as consolidation after objective response to taxane chemotherapy in women with HER2-negative metastatic breast cancer
Wildiers, H, Fontaine, C, Vuylsteke, P, Martens, M, Canon, J. L, Wynendaele, W, Focan, C, De Greve, J, Squifflet, P, Paridaens, R
Published in Breast cancer research and treatment (01.09.2010)
Published in Breast cancer research and treatment (01.09.2010)
Get full text
Journal Article
Prognostic value of EndoPredict test in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative primary breast cancer screened for the randomized, double-blind, phase III UNIRAD trial
Penault-Llorca, F., Dalenc, F., Chabaud, S., Cottu, P., Allouache, D., Cameron, D., Grenier, J., Venat Bouvet, L., Jegannathen, A., Campone, M., Debled, M., Hardy-Bessard, A.-C., Giacchetti, S., Barthelemy, P., Kaluzinski, L., Mailliez, A., Mouret-Reynier, M.-A., Legouffe, E., Cayre, A., Martinez, M., Delbaldo, C., Mollon-Grange, D., Macaskill, E.J., Sephton, M., Stefani, L., Belgadi, B., Winter, M., Orfeuvre, H., Lacroix-Triki, M., Bonnefoi, H., Bliss, J., Canon, J.-L., Lemonnier, J., Andre, F., Bachelot, T.
Published in ESMO open (01.05.2024)
Published in ESMO open (01.05.2024)
Get full text
Journal Article
Cardiac safety of adjuvant pegylated liposomal doxorubicin with concurrent trastuzumab: a randomized phase II trial
Rayson, D., Suter, T.M., Jackisch, C., van der Vegt, S., Bermejo, B., van den Bosch, J., Vivanco, G.L., van Gent, A.M., Wildiers, H., Torres, A., Provencher, L., Temizkan, M., Chirgwin, J., Canon, J.L., Ferrandina, G., Srinivasan, S., Zhang, L., Richel, D.J.
Published in Annals of oncology (01.07.2012)
Published in Annals of oncology (01.07.2012)
Get full text
Journal Article
Tumor lysis syndrome following trastuzumab and pertuzumab for metastatic breast cancer: a case report
Baudon, C, Duhoux, F P, Sinapi, I, Canon, J L
Published in Journal of medical case reports (16.06.2016)
Published in Journal of medical case reports (16.06.2016)
Get full text
Journal Article
PRECISION: the Belgian molecular profiling program of metastatic cancer for clinical decision and treatment assignment
Thouvenin, J., Van Marcke, C., Decoster, L., Raicevic, G., Punie, K., Vandenbulcke, M., Salgado, R., Van Valckenborgh, E., Maes, B., Joris, S., Steichel, D. Vander, Vranken, K., Jacobs, S., Dedeurwaerdere, F., Martens, G., Devos, H., Duhoux, F.P., Rasschaert, M., Pauwels, P., Geboes, K., Collignon, J., Tejpar, S., Canon, J.-L., Peeters, M., Rutten, A., Van de Mooter, T., Vermeij, J., Schrijvers, D., Demey, W., Lybaert, W., Van Huysse, J., Mebis, J., Awada, A., Claes, K.B.M., Hebrant, A., Van der Meulen, J., Delafontaine, B., Bempt, I. Vanden, Maetens, J., de Hemptinne, M., Rottey, S., Aftimos, P., De Grève, J.
Published in ESMO open (01.08.2022)
Published in ESMO open (01.08.2022)
Get full text
Journal Article
Web Resource
High prevalence of anaemia and limited use of therapy in cancer patients: a Belgian survey (Anaemia Day 2008)
Verbeke, Natacha, Beguin, Yves, Wildiers, Hans, Canon, J. L., Bries, Greet, Bosly, Andre, Van Belle, Simon
Published in Supportive care in cancer (2012)
Published in Supportive care in cancer (2012)
Get full text
Journal Article
Web Resource
Docetaxel combined with irinotecan or 5-fluorouracil in patients with advanced oesophago-gastric cancer: a randomised phase II study
ROY, A, CUNNINGHAM, D, CASTANON, C, FONSECA, E, RIXE, O, APARICIO, J, CASSINELLO, J, NICOLSON, M, MOUSSEAU, M, SCHALHORN, A, D'HONDT, L, KERGER, J, HAWKINS, R, HOSSFELD, D. K, GARCIA GIRON, C, RODRIGUEZ, R, SCHOFFSKIZ, P, MISSES, J.-L, SÖRBYE, H, ADENIS, A, BARCELO, J.-R, LOPEZ-VIVANCO, G, ADLER, G, CANON, J.-L, LOFTS, F
Published in British journal of cancer (24.07.2012)
Published in British journal of cancer (24.07.2012)
Get full text
Journal Article